CA2847581A1 - Dispositif d'embolisation a matrice en mousse - Google Patents

Dispositif d'embolisation a matrice en mousse Download PDF

Info

Publication number: CA2847581A1
Authority: CA; Canada
Prior art keywords: embolization; foam; coil; catheter; lumen
Prior art date: 2005-06-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2847581A

Other languages

English (en)

Inventor

Hiep Q. Do

Richard Champion Davis, Iii

Donald K. Jones

Juan A. Lorenzo

Vladimir Mitelberg

Darren R. Sherman

Murty Vyakarnam

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cordis Corp

Original Assignee

Cordis Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-30

Filing date

2006-06-29

Publication date

2006-12-30

2005-11-18 Priority claimed from US11/171,560 external-priority patent/US8313504B2/en

2006-06-29 Application filed by Cordis Corp filed Critical Cordis Corp

2006-12-30 Publication of CA2847581A1 publication Critical patent/CA2847581A1/fr

Status Abandoned legal-status Critical Current

Links

230000010102 embolization Effects 0.000 title claims abstract description 181
239000006260 foam Substances 0.000 title claims abstract description 146
239000011159 matrix material Substances 0.000 title description 2
230000002792 vascular Effects 0.000 claims abstract description 44
210000004204 blood vessel Anatomy 0.000 claims abstract description 26
230000007547 defect Effects 0.000 claims abstract description 8
239000006263 elastomeric foam Substances 0.000 claims abstract description 8
239000000463 material Substances 0.000 claims description 36
230000003073 embolic effect Effects 0.000 claims description 29
239000003814 drug Substances 0.000 claims description 16
229940124597 therapeutic agent Drugs 0.000 claims description 13
238000011282 treatment Methods 0.000 abstract description 7
229920000642 polymer Polymers 0.000 description 37
206010002329 Aneurysm Diseases 0.000 description 30
239000000243 solution Substances 0.000 description 23
238000000034 method Methods 0.000 description 21
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 16
210000004027 cell Anatomy 0.000 description 15
229920001577 copolymer Polymers 0.000 description 15
239000006261 foam material Substances 0.000 description 14
239000000203 mixture Substances 0.000 description 14
-1 poly(amino acids) Polymers 0.000 description 12
239000002904 solvent Substances 0.000 description 12
238000004108 freeze drying Methods 0.000 description 11
PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 11
238000000576 coating method Methods 0.000 description 10
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 9
229920000954 Polyglycolide Polymers 0.000 description 9
239000011248 coating agent Substances 0.000 description 9
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
229920001198 elastomeric copolymer Polymers 0.000 description 8
229910052751 metal Inorganic materials 0.000 description 8
239000002184 metal Substances 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 7
229910052697 platinum Inorganic materials 0.000 description 7
239000011148 porous material Substances 0.000 description 7
229920001971 elastomer Polymers 0.000 description 6
239000000806 elastomer Substances 0.000 description 6
239000000835 fiber Substances 0.000 description 6
239000000017 hydrogel Substances 0.000 description 6
239000007788 liquid Substances 0.000 description 6
238000004519 manufacturing process Methods 0.000 description 6
230000008569 process Effects 0.000 description 6
239000012779 reinforcing material Substances 0.000 description 6
YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 6
VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 description 5
102000008186 Collagen Human genes 0.000 description 5
108010035532 Collagen Proteins 0.000 description 5
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 5
239000004372 Polyvinyl alcohol Substances 0.000 description 5
229920001436 collagen Polymers 0.000 description 5
235000014655 lactic acid Nutrition 0.000 description 5
239000004310 lactic acid Substances 0.000 description 5
229920001610 polycaprolactone Polymers 0.000 description 5
229920002451 polyvinyl alcohol Polymers 0.000 description 5
235000019422 polyvinyl alcohol Nutrition 0.000 description 5
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 5
102000016359 Fibronectins Human genes 0.000 description 4
108010067306 Fibronectins Proteins 0.000 description 4
230000008901 benefit Effects 0.000 description 4
229920002988 biodegradable polymer Polymers 0.000 description 4
239000004621 biodegradable polymer Substances 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
230000004663 cell proliferation Effects 0.000 description 4
239000000470 constituent Substances 0.000 description 4
238000001816 cooling Methods 0.000 description 4
238000002594 fluoroscopy Methods 0.000 description 4
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
239000010931 gold Substances 0.000 description 4
150000002739 metals Chemical class 0.000 description 4
229910052757 nitrogen Inorganic materials 0.000 description 4
239000002245 particle Substances 0.000 description 4
229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
239000001267 polyvinylpyrrolidone Substances 0.000 description 4
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
238000012800 visualization Methods 0.000 description 4
JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 3
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
108050007372 Fibroblast Growth Factor Proteins 0.000 description 3
102000018233 Fibroblast Growth Factor Human genes 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 3
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 3
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 3
208000009443 Vascular Malformations Diseases 0.000 description 3
208000027418 Wounds and injury Diseases 0.000 description 3
229920003232 aliphatic polyester Polymers 0.000 description 3
229910045601 alloy Inorganic materials 0.000 description 3
239000000956 alloy Substances 0.000 description 3
238000006065 biodegradation reaction Methods 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
229940079593 drug Drugs 0.000 description 3
229940126864 fibroblast growth factor Drugs 0.000 description 3
238000007710 freezing Methods 0.000 description 3
230000008014 freezing Effects 0.000 description 3
229910052737 gold Inorganic materials 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
229910052740 iodine Inorganic materials 0.000 description 3
239000011630 iodine Substances 0.000 description 3
239000000178 monomer Substances 0.000 description 3
239000002953 phosphate buffered saline Substances 0.000 description 3
239000004633 polyglycolic acid Substances 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
239000007787 solid Substances 0.000 description 3
229910052715 tantalum Inorganic materials 0.000 description 3
229910052721 tungsten Inorganic materials 0.000 description 3
239000010937 tungsten Substances 0.000 description 3
210000005166 vasculature Anatomy 0.000 description 3
JJTUDXZGHPGLLC-ZXZARUISSA-N (3r,6s)-3,6-dimethyl-1,4-dioxane-2,5-dione Chemical compound C[C@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-ZXZARUISSA-N 0.000 description 2
BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 2
KKGSHHDRPRINNY-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1.O=C1COCCO1 KKGSHHDRPRINNY-UHFFFAOYSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
206010016717 Fistula Diseases 0.000 description 2
201000008450 Intracranial aneurysm Diseases 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
229910001260 Pt alloy Inorganic materials 0.000 description 2
208000007536 Thrombosis Diseases 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
229910052782 aluminium Inorganic materials 0.000 description 2
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
210000001367 artery Anatomy 0.000 description 2
239000002131 composite material Substances 0.000 description 2
238000007906 compression Methods 0.000 description 2
230000006835 compression Effects 0.000 description 2
229940039231 contrast media Drugs 0.000 description 2
239000002872 contrast media Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000000945 filler Substances 0.000 description 2
238000011049 filling Methods 0.000 description 2
230000003890 fistula Effects 0.000 description 2
239000012530 fluid Substances 0.000 description 2
238000005187 foaming Methods 0.000 description 2
238000009472 formulation Methods 0.000 description 2
239000007789 gas Substances 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
239000012456 homogeneous solution Substances 0.000 description 2
229920001519 homopolymer Polymers 0.000 description 2
230000007774 longterm Effects 0.000 description 2
230000005012 migration Effects 0.000 description 2
238000013508 migration Methods 0.000 description 2
238000012856 packing Methods 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229920000747 poly(lactic acid) Polymers 0.000 description 2
229920002959 polymer blend Polymers 0.000 description 2
230000002062 proliferating effect Effects 0.000 description 2
239000012783 reinforcing fiber Substances 0.000 description 2
230000004044 response Effects 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
238000000527 sonication Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
WTKKCYNZRWIVKL-UHFFFAOYSA-N tantalum Chemical compound [Ta+5] WTKKCYNZRWIVKL-UHFFFAOYSA-N 0.000 description 2
230000007704 transition Effects 0.000 description 2
238000011277 treatment modality Methods 0.000 description 2
UJGHGRGFKZWGMS-UHFFFAOYSA-N 1,3-dioxan-2-one Chemical compound O=C1OCCCO1.O=C1OCCCO1 UJGHGRGFKZWGMS-UHFFFAOYSA-N 0.000 description 1
208000022211 Arteriovenous Malformations Diseases 0.000 description 1
206010003226 Arteriovenous fistula Diseases 0.000 description 1
239000004604 Blowing Agent Substances 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
206010053567 Coagulopathies Diseases 0.000 description 1
102000016942 Elastin Human genes 0.000 description 1
108010014258 Elastin Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
208000005422 Foreign-Body reaction Diseases 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
101150097381 Mtor gene Proteins 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
229920002732 Polyanhydride Polymers 0.000 description 1
229920001710 Polyorthoester Polymers 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
206010053648 Vascular occlusion Diseases 0.000 description 1
229910001080 W alloy Inorganic materials 0.000 description 1
PNDPGZBMCMUPRI-XXSWNUTMSA-N [125I][125I] Chemical compound [125I][125I] PNDPGZBMCMUPRI-XXSWNUTMSA-N 0.000 description 1
HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
210000003484 anatomy Anatomy 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000005744 arteriovenous malformation Effects 0.000 description 1
229910052788 barium Inorganic materials 0.000 description 1
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
239000012867 bioactive agent Substances 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
239000000560 biocompatible material Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
239000012620 biological material Substances 0.000 description 1
229920001222 biopolymer Polymers 0.000 description 1
208000021138 brain aneurysm Diseases 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
238000005266 casting Methods 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000021164 cell adhesion Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000003399 chemotactic effect Effects 0.000 description 1
239000012829 chemotherapy agent Substances 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
230000035602 clotting Effects 0.000 description 1
239000008199 coating composition Substances 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
238000005056 compaction Methods 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
229920002549 elastin Polymers 0.000 description 1
239000013536 elastomeric material Substances 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
230000003176 fibrotic effect Effects 0.000 description 1
239000013305 flexible fiber Substances 0.000 description 1
229920005570 flexible polymer Polymers 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000012634 fragment Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
150000001261 hydroxy acids Chemical class 0.000 description 1
239000005457 ice water Substances 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000002513 implantation Methods 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
229940044173 iodine-125 Drugs 0.000 description 1
150000002596 lactones Chemical class 0.000 description 1
238000002386 leaching Methods 0.000 description 1
238000012792 lyophilization process Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000002483 medication Methods 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
229920005615 natural polymer Polymers 0.000 description 1
229910001000 nickel titanium Inorganic materials 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
230000008520 organization Effects 0.000 description 1
150000003891 oxalate salts Chemical class 0.000 description 1
238000005191 phase separation Methods 0.000 description 1
229920001308 poly(aminoacid) Polymers 0.000 description 1
229920001982 poly(ester urethane) Polymers 0.000 description 1
229920002627 poly(phosphazenes) Polymers 0.000 description 1
229920001281 polyalkylene Polymers 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
239000004632 polycaprolactone Substances 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
238000006068 polycondensation reaction Methods 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229920001299 polypropylene fumarate Polymers 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
230000002028 premature Effects 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000007112 pro inflammatory response Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000005855 radiation Effects 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
239000012857 radioactive material Substances 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000003938 response to stress Effects 0.000 description 1
238000007151 ring opening polymerisation reaction Methods 0.000 description 1
239000000523 sample Substances 0.000 description 1
238000007789 sealing Methods 0.000 description 1
239000008259 solid foam Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
238000000859 sublimation Methods 0.000 description 1
230000008022 sublimation Effects 0.000 description 1
239000000758 substrate Substances 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
229910052719 titanium Inorganic materials 0.000 description 1
239000010936 titanium Substances 0.000 description 1
229910001258 titanium gold Inorganic materials 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
230000006496 vascular abnormality Effects 0.000 description 1
208000021331 vascular occlusion disease Diseases 0.000 description 1
210000003462 vein Anatomy 0.000 description 1

Landscapes

Surgical Instruments (AREA)

CA2847581A 2005-06-30 2006-06-29 Dispositif d'embolisation a matrice en mousse Abandoned CA2847581A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11/171,560		2005-06-30
US11/171,560 US8313504B2 (en)	2000-09-18	2005-11-18	Foam matrix embolization device
CA2551373A CA2551373C (fr)	2005-06-30	2006-06-29	Dispositif d'embolisation a matrice en mousse

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2551373A Division CA2551373C (fr)	2005-06-30	2006-06-29	Dispositif d'embolisation a matrice en mousse

Publications (1)

Publication Number	Publication Date
CA2847581A1 true CA2847581A1 (fr)	2006-12-30

Family

ID=50680219

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2847581A Abandoned CA2847581A1 (fr)	2005-06-30	2006-06-29	Dispositif d'embolisation a matrice en mousse

Country Status (1)

Country	Link
CA (1)	CA2847581A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2017212449A1 (fr) *	2016-06-10	2017-12-14	University Of Cape Town	Dispositif implantable

2006
- 2006-06-29 CA CA2847581A patent/CA2847581A1/fr not_active Abandoned

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2017212449A1 (fr) *	2016-06-10	2017-12-14	University Of Cape Town	Dispositif implantable
US12016547B2 (en)	2016-06-10	2024-06-25	University Of Cape Town	Implantable device
US12232719B2 (en)	2016-06-10	2025-02-25	University Of Cape Town	Implantable device

Legal Events

Date	Code	Title	Description
2014-05-08	EEER	Examination request	Effective date: 20140324
2019-08-13	FZDE	Dead	Effective date: 20190702

Publication	Publication Date	Title
CA2551373C (fr)	2014-06-03	Dispositif d'embolisation a matrice en mousse
EP1188414B1 (fr)	2007-11-07	Dispositif pour embolisation intravasculaire
CA2501526C (fr)	2013-07-16	Dispositif d'occlusion vasculaire avec revetement elastomerique bioresorbable
US20030004568A1 (en)	2003-01-02	Coated combination vaso-occlusive device
US20040098023A1 (en)	2004-05-20	Embolic device made of nanofibers
US20050149109A1 (en)	2005-07-07	Expanding filler coil
WO2005070015A9 (fr)	2005-11-03	Dispositifs et procedes pour le traitement endovasculaire
JP2009530042A (ja)	2009-08-27	動脈瘤閉塞用自己拡張型血管内デバイス
JP2008521492A (ja)	2008-06-26	脈管閉塞器具及び方法
JP2007510464A (ja)	2007-04-26	塞栓組成物
US20070078480A1 (en)	2007-04-05	Self-expanding biodegradable or water-soluble vaso-occlusive devices
JP5063603B2 (ja)	2012-10-31	被覆された血管閉塞装置
JP2008526442A (ja)	2008-07-24	付着されたポリマー構造を有する脈管閉塞デバイス
US20200069836A1 (en)	2020-03-05	Polymer-based arterial hemangioma embolization device, manufacturing method and application of same
US20070078479A1 (en)	2007-04-05	Self-expanding vaso-occlusive devices with regulated expansion
Karadeli et al.	2024	Single component polymers, polymer blends, and polymer composites for interventional endovascular embolization of intracranial aneurysms
CA2847581A1 (fr)	2006-12-30	Dispositif d'embolisation a matrice en mousse
EP1738695A1 (fr)	2007-01-03	Procédé de fabrication d'un dispositif d'embolisation revêtu
HK1132649A (en)	2010-03-05	Self-expandable endovascular device for aneurysm occlusion